Compare UAA & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UAA | INSP |
|---|---|---|
| Founded | 1996 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.2B |
| IPO Year | N/A | 2018 |
| Metric | UAA | INSP |
|---|---|---|
| Price | $6.97 | $63.39 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 16 | 16 |
| Target Price | $6.48 | ★ $102.86 |
| AVG Volume (30 Days) | ★ 10.1M | 1.4M |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | N/A | ★ 4.89 |
| Revenue | N/A | ★ $82,050,000.00 |
| Revenue This Year | N/A | $8.70 |
| Revenue Next Year | $1.72 | $9.05 |
| P/E Ratio | ★ N/A | $13.21 |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $4.13 | $53.11 |
| 52 Week High | $8.15 | $189.49 |
| Indicator | UAA | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 47.57 | 41.07 |
| Support Level | $6.18 | $53.11 |
| Resistance Level | $7.39 | $83.68 |
| Average True Range (ATR) | 0.35 | 5.16 |
| MACD | -0.13 | 1.63 |
| Stochastic Oscillator | 4.78 | 32.68 |
Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and Latin America. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through wholesale partners, company-owned digital channels, and approximately 450 company-owned outlet and full-price stores. The Baltimore-based firm was founded in 1996 and is led by controlling shareholder Kevin Plank.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.